Save-the-date: Launch event of the Global Health EDCTP3 Joint Undertaking
On 10 May 2022, the Global Health EDCTP3 JU (GH EDCTP3 JU) will host its launch event.
During this event, GH EDCTP3 partners and other speakers will:
- Highlight the importance of the GH EDCTP3 JU to ensure research & innovation collaboration, cooperation and funding in the area of infectious diseases and the commitment of the partners to such endeavors
- Present the achievements of the previous programme, how the new partnership will build on them, and describe the new features of the GH EDCTP3 JU
- Participate in a panel discussion of the objectives and ambitions for the new partnership
This will be a hybrid in-person and virtual event. The in-person event will be hosted by ANRS | Emerging Infectious Diseases in Paris. Links to connect virtually will be published on the GH EDCTP3 JU website closer to May 10, 2022.
The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) builds on the first and second European and Developing Countries Clinical Trials Partnership programmes. This new joint undertaking is a partnership between the EU and the EDCTP Association, whose members include European and African countries.
This partnership will deliver new solutions for reducing the burden of infectious diseases in sub-Saharan Africa and strengthen research capacities to prepare and respond to re-emerging infectious diseases in this region and across the world.
By 2030, the GH EDCTP3 aims to develop and deploy at least two new technologies tackling infectious diseases, and support at least 100 research institutes in 30 countries to develop additional health technologies against infectious diseases.